abstract Glioblastoma is the most frequent, the most malignant and the best vascularised primary brain tumor. Substantial evidence suggests that IGFBP-2 (insulin-like growth factor binding protein) may play a significant role in the development and progression of various types of cancer, including the anaplastic progression of astroglial tumors. The correlation of IGFBP-2 and VEGF over-expression in diffuse gliomas and strong IGFBP-2 immunostaining and co-expression with VEGF in the cells of pseudopalisading necrosis suggests the induction of IGFBP-2 expression by hypoxia and/or possible involvement of its protein product in angiogenesis. The aim of this study was to analyze the expression of IGFBP-2 and the relationship between the IGFBP-2 expression, extent of bizarre angiogenesis and the presence of pseudopalisades. The prognostic impact of these variables was estimated, as well. Our results revealed that most glioblastoma (75%) express IGFBP2 and that IGFBP2 expression was associated with the presence of pseudopalisading necrosis as well as extensive bizarre angiogenesis. IGFBP-2 immunoreactivity in more than 5% of tumor cells and the presence of pseudopalisading necrosis were prognostically significant in univariate analysis (p=0.034) while in multivariate analysis only a patient's age and the presence of pseudopalisades remained statistically significant (p=0.004). The results of our study showed the association of IGFBP-2 expression in glioblastoma with pseudopalisades and bizarre angiogenesis thus confirming on morphological grounds presumed induction of this gene under hypoxic conditions and its possible role in angiogenesis.
Introduction
Glioblastoma is the most common primary brain tumor and one of the most malignant human neoplasms. It accounts for 12-15% of all intracranial neoplasms and 60-75% of glial tumors [1] . Median survival time is only 12-14 months [2, 3] . garlands and vascular clusters [4] . Necrosis, particularly pseudopalisading type, and bizarre angiogenesis are morphological hallmarks of glioblastoma that distinguish this glioma from other infiltrative astrocytomas of lower grade [5] .
IGFBP-2 (insulin-like growth factor binding
protein) is one of the seven peptides with a high affinity for insulin-like growth factors (IGF) [6, 7] . By sequestering IGFs away from the type I IGF receptor, IGFBPs may inhibit mitogenesis, differentiation, survival, and other IGF-stimulated events [6, 8, 9] . Substantial evidence suggests that IGFBP-2 over-expression might be related to development and progression of various types of cancer [9] [10] [11] [12] [13] [14] [15] [16] . Serum IGFBP-2 level is elevated in several malignant diseases such as prostatic [17] [18] [19] , ovarial [20] [21] [22] , and gastro-intestinal cancers [23, 24] . IGFBP-2 expression in atypical and neoplastic prostatic and epithelium, but not in normal or hyperplastic type, suggests that it could be an independent marker of neoplastic transformation [9, 25, 26] . The strong correlation between over-expression of IGFBP-2 and histologic grade implies that IGFBP-2 may play a significant role in glioma progression [27] [28] [29] [30] [31] [32] [33] .
IGFBP-2 possibly controls the cellular
functions that are crucial in determining the phenotypes of advanced stages of cancer, such as cell proliferation, angiogenesis and invasion [32, 34, 35] . Reactivation of IGFBP-2 in glioblastoma is accompanied by the overexpression of VEGF and vascular proliferation suggesting the possible role of IGFBP-2 in tumor angiogenesis. Strong IGFBP-2 immunostaining and co expression with VEGF in the cells of pseudopalisades suggests the induction of this gene by hypoxia [16, 33, 36, 37] . Overall survival was defined from the day of the initial surgery until death of the patient.
Survival until the end of the observation was considered as censored observation. For all tests, a 2-tailed p-value of ≤0.05 was considered as significant. 
results
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discussion
Glioblastoma is the most frequent, the They suggest that IGFBP-2 may contribute significantly to glioblastoma pathogenesis by promoting stem-cell proliferation and survival.
Moore et al. indicated that IGFBP-2 behaves as
an oncogenic driver in glioma progression [40] .
Association of immunohistochemically and hypoxic injury to the rat brain supports this hypothesis [33, 36] . Hypoxic conditions associated with necrosis probably induce angiogenic response and this could explain the intimate relationship between necrosis and glomeruloid bodies in glial neoplasms [41] .
However, it remains unclear whether IGFBP-2 expression is intricately involved in the process of angiogenesis or whether it is merely a consequence of the hypoxic environment [28] .
According to some authors vascular patterns significantly influence clinical outcome in primary glioblastomas [4] but not in ependymomas [42] . In our study no association was found between the extent of bizarre angiogenesis and survival. This disagreement with the previously published results [4] might be a consequence of the poor interobserver agreement already noticed in the vascular pattern recognition [43] .
Although the prognosis for patients with glioblastoma is poor, survival is variable and 3-5% are known to survive for more than 3 years Translational Neuroscience
